Two Hands Corp. Files 8-K/A Amendment
Ticker: TWOH · Form: 8-K/A · Filed: Jan 24, 2025 · CIK: 1494413
| Field | Detail |
|---|---|
| Company | Two Hands Corp (TWOH) |
| Form Type | 8-K/A |
| Filed Date | Jan 24, 2025 |
| Risk Level | medium |
| Pages | 3 |
| Reading Time | 4 min |
| Sentiment | neutral |
Sentiment: neutral
Topics: corporate-governance, executive-compensation, amendment, financial-statements
TL;DR
Two Hands Corp. amended its 8-K filing, updating info on exec changes and financials.
AI Summary
Two Hands Corp. filed an amendment (8-K/A) on January 24, 2025, related to events on January 3, 2025. The filing concerns the departure of directors or certain officers, election of directors, appointment of certain officers, and compensatory arrangements for certain officers. It also includes financial statements and exhibits.
Why It Matters
This amendment provides updated information regarding corporate governance changes and executive compensation, which can impact investor confidence and the company's strategic direction.
Risk Assessment
Risk Level: medium — Amendments to 8-K filings, especially those concerning director/officer changes and compensation, can indicate internal shifts that may carry inherent business risks.
Key Players & Entities
- Two Hands Corp. (company) — Registrant
- January 3, 2025 (date) — Earliest event date
- January 24, 2025 (date) — Filing date
- Delaware (jurisdiction) — State of incorporation
- 141 Piping Rock Road, Locust Valley, New York 11560 (address) — Principal business address
FAQ
What specific director or officer departures are detailed in this 8-K/A filing?
The filing indicates events related to the 'Departure of Directors or Certain Officers' but does not specify names or exact details within the provided text.
What is the primary reason for filing this 8-K/A amendment?
The amendment is filed to update information concerning director/officer changes, elections, appointments, and compensatory arrangements, as well as to include financial statements and exhibits.
When was the earliest event reported in this filing?
The earliest event reported was on January 3, 2025.
What is the company's principal business address?
The company's principal business address is 141 Piping Rock Road, Locust Valley, New York 11560.
What is the SIC code for Two Hands Corp.?
The Standard Industrial Classification (SIC) code for Two Hands Corp. is 7389, which falls under SERVICES-BUSINESS SERVICES, NEC.
Filing Stats: 986 words · 4 min read · ~3 pages · Grade level 11.7 · Accepted 2025-01-24 08:19:53
Filing Documents
- twoh8k1225.htm (8-K/A) — 32KB
- 0001262463-25-000037.txt ( ) — 200KB
- twoh-20250103.xsd (EX-101.SCH) — 3KB
- twoh-20250103_lab.xml (EX-101.LAB) — 33KB
- twoh-20250103_pre.xml (EX-101.PRE) — 24KB
- twoh8k1225_htm.xml (XML) — 3KB
02 Departure of Directors
Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain officers; Compensatory Arrangements of Certain Officers. On January 3, 2025, the Company accepted the resignation from Emil Assentato as the Company's Chief Financial Officer. Effective on the same date to fill the vacancy created by Mr. Assentato' resignation, the Board of Directors appointed Andrew Kucharchuk as the Company's Chief Financial Officer. This resignation was not the result of any disagreement with Company on any matter relating to Company's operations, policies or practices. Emil Assentato will continue to serve as Chief Executive Officer, President, Treasurer, Secretary and a member of the Board of Directors of the Company. In addition, effective January 3, 2025, the Board of Directors appointed Andrew Kucharchuk and Craig Marshak as members of the Board of Directors. The Board now consists of Emil Assentato, Andrew Kucharchuk and Craig Marshak. The following biographical information is provided: Andrew Kucharchuk, Chief Financial Officer and Member of the Board of Directors Mr. Kucharchuk has been a director of Adhera Therapeutics Inc. since July 7, 2022, and currently serves as its Chief Operating Officer, a position he has held since September 30, 2022. Previously, he was Chief Executive Officer of Adhera Therapeutics from July 7, 2020, to September 30, 2022. Mr. Kucharchuk has been a member of the Board of Directors of Theralink Technologies, Inc. ("Theralink") since 2020, having previously served in this role from September 2015 to March 2017. His executive experience at Theralink includes roles as President and Chief Financial Officer from February 2016 to June 2020, Chief Executive Officer from November 2019 to June 2020, and Acting Chief Financial Officer from June 2020 to September 2020. Craig Marshak, Member of the Board of Directors Mr. Marshak has been a Managing Director at Clear Think Capital since joining the firm in March
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Date: January 24, 2025 TWO HANDS CORPORATION By: /s/ Emil Assentato Emil Assentato Chief Executive Officer 3